Evidence map›Paper›PMID 30333321›Full record

ArticleJCI insight2018

Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism.

Hakan Cangul, Xiao-Hui Liao, Erik Schoenmakers, Jukka Kero, Sharon Barone, Panudda Srichomkwun, Hideyuki Iwayama, Eva G Serra, Halil Saglam, Erdal Eren and 18 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Guideline
  2. Approach to the patient: genetics and management of congenital hypothyroidism.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Review
  4. Review
  5. InvestigatingFrontiers in endocrinology · 2025
    Article
  6. Review
  7. CouldDiagnostics (Basel, Switzerland) · 2024
    Article
  8. Deciphering the mystery of CHNG3.Annals of pediatric endocrinology & metabolism · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision).Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 4 countries.

Hakan CangulDepartment of Medical Genetics, Istanbul Medipol University, International School of Medicine, Istanbul, Turkey.
Xiao-Hui LiaoDepartment of Medicine, The University of Chicago, Chicago, Illinois, USA.
Erik SchoenmakersMetabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom (UK).
Jukka KeroResearch Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
Sharon BaroneUniversity of Cincinnati and Veterans Administration Hospital, Cincinnati, Ohio, USA.
Panudda SrichomkwunDepartment of Medicine, The University of Chicago, Chicago, Illinois, USA.
Hideyuki IwayamaDepartment of Medicine, The University of Chicago, Chicago, Illinois, USA.
Eva G SerraDepartment of Human Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Halil SaglamUludag University School of Medicine, Department of Paediatric Endocrinology, Bursa, Turkey.
Erdal ErenUludag University School of Medicine, Department of Paediatric Endocrinology, Bursa, Turkey.
Omer TarimUludag University School of Medicine, Department of Paediatric Endocrinology, Bursa, Turkey.
Adeline K NicholasMetabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom (UK).
Ilona ZvetkovaMetabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom (UK).
Carl A AndersonDepartment of Human Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Fiona E Karet FranklDepartment of Medical Genetics and Division of Renal Medicine, University of Cambridge, Cambridge, UK.
Kristien BoelaertInstitute of Metabolism and Systems Research, University of Birmingham and Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Edgbaston, Birmingham, UK.
Marja OjaniemiPEDEGO Research Center and MRC Oulu, University of Oulu, and Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
Jarmo JääskeläinenDepartment of Pediatrics, University of Eastern Finland and Kuopio University, Hospital, Kuopio, Finland.
Konrad PatyraResearch Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
Christoffer LöfResearch Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
E Dillwyn WilliamsThyroid Carcinogenesis Group, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
UK10K Consortium
Manoocher SoleimaniUniversity of Cincinnati and Veterans Administration Hospital, Cincinnati, Ohio, USA.
Timothy BarrettInstitute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham and Department of Endocrinology, Birmingham Children's Hospital, Birmingham, UK.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
V Krishna ChatterjeeMetabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom (UK).
Samuel RefetoffDepartment of Medicine, The University of Chicago, Chicago, Illinois, USA.
Nadia SchoenmakersMetabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom (UK).
Wellcome/MRC Institute of Metabolic Science · GBUniversity of Chicago · USBursa Uludağ Üni̇versi̇tesi̇ · TRUniversity of Turku · FIUniversity of Cambridge · GBUniversity of Cincinnati · USWellcome Sanger Institute · GBBirmingham Children's Hospital · GBIstanbul Medipol University · TROulu University Hospital · FITissue Genetics (United States) · USUniversity of Birmingham · GBUniversity of Eastern Finland · FI

Funding

THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR01DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI ANTONIO C BIANCO, Alexandra Mihaela Dumitrescu · 1986 to 2026
$8.1M
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR37DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI REFETOFF, SAMUEL · 1989 to 2015
$5.6M
The Role of Intercalated Cells and Their Acid Base and Electrolyte Transport Machinery in Kidney Cystogenesis by Tuberous SclerosisI01BX001000 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI SOLEIMANI, MANOOCHER · 2012 to 2025
–
BLRD VA I01 BX001000Department of HealthMedical Research Council G0502115Medical Research Council G0600717Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/5NIDDK NIH HHS R01 DK015070NIDDK NIH HHS R37 DK015070Wellcome TrustWellcome Trust 095564/Z/11/ZWellcome Trust 098051Wellcome Trust 100574/Z/12/ZWellcome Trust 100585/Z/12/ZWellcome Trust WT091310
6 · The paper itself

Abstract

Defects in genes mediating thyroid hormone biosynthesis result in dyshormonogenic congenital hypothyroidism (CH). Here, we report homozygous truncating mutations in SLC26A7 in 6 unrelated families with goitrous CH and show that goitrous hypothyroidism also occurs in Slc26a7-null mice. In both species, the gene is expressed predominantly in the thyroid gland, and loss of function is associated with impaired availability of iodine for thyroid hormone synthesis, partially corrected in mice by iodine supplementation. SLC26A7 is a member of the same transporter family as SLC26A4 (pendrin), an anion exchanger with affinity for iodide and chloride (among others), whose gene mutations cause congenital deafness and dyshormonogenic goiter. However, in contrast to pendrin, SLC26A7 does not mediate cellular iodide efflux and hearing in affected individuals is normal. We delineate a hitherto unrecognized role for SLC26A7 in thyroid hormone biosynthesis, for which the mechanism remains unclear.

Indexed as

AdultAnimalsAntiportersChildChild, PreschoolCodon, NonsenseCongenital HypothyroidismDNA Mutational AnalysisExome SequencingFemaleGoiterHEK293 CellsHomozygoteHumansMaleMiceAntiportersCodon, NonsenseSlc26a4 protein, mouseSLC26A7 protein, humanSulfate TransportersEndocrinologyGeneticsMolecular geneticsMonogenic diseasesThyroid disease

Identifiers

PMID30333321
PMCPMC6237461
OpenAlexW2896276361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.